Business Context and Reporting Period
This Form 8-K was filed by Arteleo Biosciences, Inc. on March 6, 2019. The company is incorporated in Nevada and identifies as an emerging growth company. The report details a specific corporate event regarding intellectual property rather than a standard financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory milestone and contains no financial statements or quantitative financial data.
Material Changes
The material event reported is the receipt of a Notice of Allowance from the United States Patent and Trademark Office (USPTO) on March 6, 2019. The allowance covers U.S. Patent Application Number 16/214,913, titled "New Solid Forms of Cannabidiol and Uses Thereof."
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks, contingencies, or unusual items were disclosed in this document beyond the standard regulatory context of the patent application.
Investor Verification Checklist
- Verify the final issuance date and number of the granted patent with the USPTO.
- Confirm the scope of the patent claims regarding "New Solid Forms of Cannabidiol."
- Review subsequent filings for any financial impact or commercialization plans related to this patent.